Avoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate Offer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. HOOD
10. IBM

Go back to Avoro Capital Releases Presentation Detailing Why Acceleron Shareholders Should Not Tender Into Merck’s Inadequate Offer
Merck & Co. (NYSE: MRK) Delayed: 115.48 +1.61 (1.41%)
Previous Close $113.87    52 Week High $65.46 
Open $113.97    52 Week Low $47.97 
Day High $115.63    P/E 78.56 
Day Low $113.00    EPS $1.47 
Volume 10,502,756       

ACCELERON PHARMA (NASDAQ: XLRN) Delayed: 178.75 --0 (-0%)
Previous Close $178.75    52 Week High $50.86 
Open $178.75    52 Week Low $22.67 
Day High $178.75    P/E 16.93 
Day Low $178.75    EPS $10.56 
Volume 158,297